217 related articles for article (PubMed ID: 32335294)
1. Urinary proteome and metabolome in dogs (Canis lupus familiaris): The effect of chronic kidney disease.
Ferlizza E; Isani G; Dondi F; Andreani G; Vasylyeva K; Bellei E; Almeida AM; Matzapetakis M
J Proteomics; 2020 Jun; 222():103795. PubMed ID: 32335294
[TBL] [Abstract][Full Text] [Related]
2. The effect of chronic kidney disease on the urine proteome in the domestic cat (Felis catus).
Ferlizza E; Campos A; Neagu A; Cuoghi A; Bellei E; Monari E; Dondi F; Almeida AM; Isani G
Vet J; 2015 Apr; 204(1):73-81. PubMed ID: 25726445
[TBL] [Abstract][Full Text] [Related]
3. Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention.
Dubin RF; Rhee EP
Clin J Am Soc Nephrol; 2020 Mar; 15(3):404-411. PubMed ID: 31636087
[TBL] [Abstract][Full Text] [Related]
4. Urinary Tamm-Horsfall protein, albumin, vitamin D-binding protein, and retinol-binding protein as early biomarkers of chronic kidney disease in dogs.
Chacar F; Kogika M; Sanches TR; Caragelasco D; Martorelli C; Rodrigues C; Capcha JMC; Chew D; Andrade L
Physiol Rep; 2017 Jun; 5(11):. PubMed ID: 28576851
[TBL] [Abstract][Full Text] [Related]
5. Rule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data.
Luck M; Bertho G; Bateson M; Karras A; Yartseva A; Thervet E; Damon C; Pallet N
PLoS One; 2016; 11(11):e0166905. PubMed ID: 27861591
[TBL] [Abstract][Full Text] [Related]
6. Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease.
Cañadas-Garre M; Anderson K; McGoldrick J; Maxwell AP; McKnight AJ
J Proteomics; 2019 Feb; 193():93-122. PubMed ID: 30292816
[TBL] [Abstract][Full Text] [Related]
7. The link between phenotype and fatty acid metabolism in advanced chronic kidney disease.
Chen DQ; Chen H; Chen L; Vaziri ND; Wang M; Li XR; Zhao YY
Nephrol Dial Transplant; 2017 Jul; 32(7):1154-1166. PubMed ID: 28339984
[TBL] [Abstract][Full Text] [Related]
8. Metabolome of canine and human saliva: a non-targeted metabolomics study.
Turunen S; Puurunen J; Auriola S; Kullaa AM; Kärkkäinen O; Lohi H; Hanhineva K
Metabolomics; 2020 Aug; 16(9):90. PubMed ID: 32840693
[TBL] [Abstract][Full Text] [Related]
9. Plasma metabolites associated with chronic kidney disease and renal function in adults from the Baltimore Longitudinal Study of Aging.
Yamaguchi Y; Zampino M; Moaddel R; Chen TK; Tian Q; Ferrucci L; Semba RD
Metabolomics; 2021 Jan; 17(1):9. PubMed ID: 33428023
[TBL] [Abstract][Full Text] [Related]
10. Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease.
Chen DQ; Cao G; Chen H; Liu D; Su W; Yu XY; Vaziri ND; Liu XH; Bai X; Zhang L; Zhao YY
Redox Biol; 2017 Aug; 12():505-521. PubMed ID: 28343144
[TBL] [Abstract][Full Text] [Related]
11. Pro: urine proteomics as a liquid kidney biopsy: no more kidney punctures!
Mischak H
Nephrol Dial Transplant; 2015 Apr; 30(4):532-7. PubMed ID: 25801638
[TBL] [Abstract][Full Text] [Related]
12. Multisample Mass Spectrometry-Based Approach for Discovering Injury Markers in Chronic Kidney Disease.
Kim JE; Han D; Jeong JS; Moon JJ; Moon HK; Lee S; Kim YC; Yoo KD; Lee JW; Kim DK; Kwon YJ; Kim YS; Yang SH
Mol Cell Proteomics; 2021; 20():100037. PubMed ID: 33453410
[TBL] [Abstract][Full Text] [Related]
13. Urinary proteome of dogs with kidney injury during babesiosis.
Winiarczyk D; Michalak K; Adaszek L; Winiarczyk M; Winiarczyk S
BMC Vet Res; 2019 Dec; 15(1):439. PubMed ID: 31801572
[TBL] [Abstract][Full Text] [Related]
14. Urine Metabolite Levels, Adverse Kidney Outcomes, and Mortality in CKD Patients: A Metabolome-wide Association Study.
Steinbrenner I; Schultheiss UT; Kotsis F; Schlosser P; Stockmann H; Mohney RP; Schmid M; Oefner PJ; Eckardt KU; Köttgen A; Sekula P;
Am J Kidney Dis; 2021 Nov; 78(5):669-677.e1. PubMed ID: 33839201
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.
Siwy J; Zürbig P; Argiles A; Beige J; Haubitz M; Jankowski J; Julian BA; Linde PG; Marx D; Mischak H; Mullen W; Novak J; Ortiz A; Persson F; Pontillo C; Rossing P; Rupprecht H; Schanstra JP; Vlahou A; Vanholder R
Nephrol Dial Transplant; 2017 Dec; 32(12):2079-2089. PubMed ID: 27984204
[TBL] [Abstract][Full Text] [Related]
16. Targeted MRM Quantification of Urinary Proteins in Chronic Kidney Disease Caused by Glomerulopathies.
Kononikhin AS; Brzhozovskiy AG; Bugrova AE; Chebotareva NV; Zakharova NV; Semenov S; Vinogradov A; Indeykina MI; Moiseev S; Larina IM; Nikolaev EN
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110557
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics in chronic kidney disease.
Zhao YY
Clin Chim Acta; 2013 Jun; 422():59-69. PubMed ID: 23570820
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome.
Si S; Liu H; Xu L; Zhan S
Genome Med; 2024 Jun; 16(1):84. PubMed ID: 38898508
[TBL] [Abstract][Full Text] [Related]
19. Serum uromodulin in dogs with chronic kidney disease.
Seo D; Yang Y; Hwang SH; Jung JH; Cho S; Choi G; Kim Y
J Vet Intern Med; 2022 Nov; 36(6):2071-2078. PubMed ID: 36330885
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
